Change Management Workday HCM (Contractor) at Legend Biotech

Franklin Township, New Jersey, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

BiotechnologyIndustries

Requirements

Experience leading change for global Workday implementation project is required
Skilled in training design, development and facilitation
Strong communicator with proven stakeholder management ability
Comfortable coaching leaders and employees through change

Responsibilities

Develop and execute a comprehensive change management plan aligned with the Workday project timeline and milestones
Identify change impacts across employees, managers, leaders, and HR professionals, ensuring clear mitigation strategies
Partner with project leadership to define communication, engagement, and adoption metrics
Design, develop, and deliver Workday HCM training programs (virtual, in-person)
Create role-based training materials, job aids, & quick reference guides to support users
Draft and distribute targeted communications to drive awareness, understanding, and excitement around Workday functionality
Establish feedback channels to gauge readiness and address resistance early
Champion the adoption of the Workday self-service service delivery model
Provide coaching and guidance to leaders and managers who may be unfamiliar or hesitant about self-service tools
Ensure employees at all levels gain confidence in leveraging Workday for day-to-day HR tasks
Manage change across all levels: employees, managers, senior leaders, and HR teams
Partner closely with HR leadership to embed new ways of working and sustain long-term utilization

Skills

Workday

HCM

Change Management

Stakeholder Engagement

Training Design

Training Delivery

Risk Management

Communications

HR Systems

Project Management

Legend Biotech

Develops and commercializes cell therapies

About Legend Biotech

Legend Biotech develops and commercializes cell therapies aimed at treating serious diseases, particularly cancers like hematological malignancies and solid tumors. Their approach is technology agnostic, allowing them to explore various methods to find effective treatments. The company operates in the personalized medicine sector, focusing on discovering, developing, and bringing new therapies to market. They generate revenue through licensing and selling their therapies, including CAR-T therapies, which involve modifying a patient's cells to combat cancer. Legend Biotech emphasizes transparency with investors, regularly updating them on financial results and business developments.

Franklin Township, New JerseyHeadquarters

2014Year Founded

$146.4MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

1,001-5,000Employees

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Paid Sick Leave

Paid Holidays

Remote Work Options

Risks

Increased competition from Amgen's Imdelltra may impact CAR-T therapy focus.

Collaboration with Multiply Labs may face technological challenges, delaying production timelines.

Financial strain from new R&D facility could affect operational focus if advancements lag.

Differentiation

Legend Biotech focuses on novel cell therapies for oncology, including CAR-T and NK cells.

The company is technology agnostic, exploring multiple platforms for effective cancer treatments.

Legend Biotech's CARVYKTI® is the first BCMA-targeted CAR-T therapy approved for second-line use.

Upsides

Recent FDA and European approvals for CARVYKTI® expand its market reach in multiple myeloma.

New R&D facility in Philadelphia boosts innovation in next-generation cell therapies.

Alan Bash's appointment could accelerate CARVYKTI®'s growth and market penetration.

Land your dream remote job 3x faster with AI

Try Jobo Free